NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 17
[ Auteur(Asc)] Titel Jaar
Filters: Eerste Letter Van De Achternaam is S  [Alle filters opschonen]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Swerts C, Vandevelde S, VanDerNagel JEl, Vanderplasschen W, Claes C, De Maeyer J.  2017.  Substance use among individuals with intellectual disabilities living independently in Flanders.. Res Dev Disabil. 63:107-117.
Stollenga M., van Oene GH de Weert.  2011.  Verslavingszorg - benchmarken en monitoren. ROM in de GGZ. Van weten naar meten.
Spijkerman E, DeJong CA.  2009.  Is dwang bij ernstig verslaafde patiënten effectief en hoe besluit je tot dwang? Verslavingsgeneeskunde: Psychofarmacologie, psychiatrie en somatiek.
Soe-Agnie SE, Paap MCS, Nijman HLI, De Jong CAJ.  2020.  Psychometric Properties of the Externalizing Spectrum Inventory: Replication and Extension across Clinical and Non-Clinical Samples.. J Pers Assess. :1-10.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review. Psychiatry Research. 259:412-421.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.. Psychiatry Res. 259:412-421.
Schellekens A, Mulder SF, van Eijndhoven PFP, Smilde TJ, van Herpen CML.  2011.  Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.. Gen Hosp Psychiatry. 33(1):83.e1-3.
Schellekens A, van Oosterwijck AWAA, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2009.  The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. Eur Neuropsychopharmacol. 1(19):73.
Schellekens A, DeJong CA, Buitelaar JK, Verkes RJ.  2014.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment.. Eur Psychiatry.
Schellekens A, de Bruijn ERA, van Lankveld CAA, Hulstijn W, Buitelaar JK, DeJong CA, Verkes RJ.  2010.  Alcohol dependence and anxiety increase error-related brain activity.. Addiction. 105(11):1928-34.
Schellekens AFA, Vanderschuren L.  2019.  Neurobiologie van verslaving. Handboek Verslaving.
Schellekens A, Kramer R, Vander Moolen A, Dumondt G, DeJong CA.  2009.  Neurofarmacologie van alcohol, cannabis, opiaten, cocaïne en nicotine. Verslavingsgeneeskunde: Psychofarmacologie, psychiatrie en somatiek.
Schellekens A, Mulders PCR, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2012.  Early-onset alcohol dependence increases the acoustic startle reflex.. Alcohol Clin Exp Res. 36(6):1075-83.
Schellekens A, van Oosterwijck AWAA, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2009.  The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls.. Eur Neuropsychopharmacol. 19(1):68-73.
Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.. Arch Gen Psychiatry. 69(4):339-48.
Schellekens A, Grootens KP, Neef C, Movig KLL, Buitelaar JK, Ellenbroek B, Verkes RJ.  2010.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.. Psychopharmacology (Berl). 207(4):559-69.
Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.. Addict Biol.